July 30, 2025
Multiple Myeloma SOHO Insider Podcast

The journey of belantamab mafodotin in multiple myeloma

Host Saad Usmani, MD, chief of the myeloma service at Memorial Sloan Kettering Cancer Center in New York City, and Sagar Lonial, MD,

Read More
Multiple Myeloma News

FDA grants accelerated approval to linvoseltamab in relapsed or refractory myeloma

The US Food and Drug Administration has granted accelerated approval to linvoseltamab (Lynozyfic) in adults patients with relapsed or refractory multiple myeloma who

Read More
EHA 2025 News Video Interviews

Low-intensity protocol targets MRD in ALL

In this video interview, Anastasia Vasileva, MD, a researcher at the National Research Center for Hematology in Moscow, discusses findings from a study

Read More
2025 ASCO News

Dr. Kuykendall discusses VERIFY trial, rusfertide’s impact on PV treatment

Andrew Kuykendall, MD, assistant member in Malignant Hematology at Moffitt Cancer Center in Tampa, Florida, discusses the phase 3 VERIFY trial primary results,

Read More
Leukemia Lymphoma Multiple Myeloma

FDA removes REMS requirement for 6 CAR-T therapies

The US Food and Drug Administration (FDA) has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for all currently approved BCMA- and CD19-directed

Read More
Leukemia Acute Myeloid Leukemia News SOHO Insider Podcast

Inside AML challenges with Drs. Jabbour, Daver

Elias Jabbour, MD, and Naval Daver, MD, both of the University of Texas MD Anderson Cancer Center, discuss challenges in TP53-mutated acute myeloid

Read More
EHA 2025

Dr. Komrokji reports imetelstat data in high-EPO MDS from EHA 2025

Rami Komrokji, MD, of Moffitt Cancer Center in Tampa, Florida, presented an update at the 2025 European Hematology Association Congress in Milan on

Read More
2025 ASCO Video Interviews

Latest COMMANDS analysis shows luspatercept is transformative in MDS

In this video interview, Guillermo Garcia-Manero, MD, chief of the section of myelodysplastic syndromes at the University of Texas MD Anderson Cancer Center,

Read More
18-IMCL Lymphoma

Gut-linked microbes tied to survival in DLBCL

The presence of certain intratumoral microbes was linked to survival outcomes in diffuse large B-cell lymphoma (DLBCL), according to findings presented at ICML

Read More
18-IMCL Lymphoma

‘Boom Boom’ Radiotherapy approach may boost CAR T-cell responses

The combination of so-called “Boom Boom” radiotherapy prior to treatment with lisocabtagene maraleucel (liso-cel) was found to be safe, feasible, and effective, according

Read More